CROCE, Carlo Maria
 Distribuzione geografica
Continente #
NA - Nord America 20.169
AS - Asia 7.875
EU - Europa 4.577
SA - Sud America 1.399
AF - Africa 109
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 7
Totale 34.145
Nazione #
US - Stati Uniti d'America 19.902
SG - Singapore 3.114
CN - Cina 2.303
BR - Brasile 1.190
UA - Ucraina 1.024
HK - Hong Kong 875
DE - Germania 787
IT - Italia 655
TR - Turchia 624
GB - Regno Unito 543
VN - Vietnam 472
PL - Polonia 399
FI - Finlandia 277
SE - Svezia 270
RU - Federazione Russa 257
MX - Messico 139
ID - Indonesia 108
IN - India 101
FR - Francia 100
CA - Canada 97
AR - Argentina 89
NL - Olanda 64
BD - Bangladesh 60
ES - Italia 49
ZA - Sudafrica 49
AT - Austria 40
JP - Giappone 38
BE - Belgio 33
EC - Ecuador 33
IQ - Iraq 27
IR - Iran 21
CO - Colombia 20
UZ - Uzbekistan 20
KR - Corea 18
PK - Pakistan 18
VE - Venezuela 18
LT - Lituania 16
MA - Marocco 14
CL - Cile 13
CZ - Repubblica Ceca 11
PY - Paraguay 11
EG - Egitto 10
AE - Emirati Arabi Uniti 9
NP - Nepal 9
PE - Perù 9
TN - Tunisia 9
UY - Uruguay 9
AL - Albania 7
AU - Australia 7
CH - Svizzera 7
SA - Arabia Saudita 7
GR - Grecia 6
HN - Honduras 6
MY - Malesia 6
OM - Oman 6
RO - Romania 6
AZ - Azerbaigian 5
DO - Repubblica Dominicana 5
DZ - Algeria 5
ET - Etiopia 5
IE - Irlanda 5
IL - Israele 5
KE - Kenya 5
BG - Bulgaria 4
BO - Bolivia 4
CR - Costa Rica 4
EU - Europa 4
JM - Giamaica 3
JO - Giordania 3
KZ - Kazakistan 3
MD - Moldavia 3
PA - Panama 3
PS - Palestinian Territory 3
QA - Qatar 3
RS - Serbia 3
SN - Senegal 3
TW - Taiwan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AM - Armenia 2
BY - Bielorussia 2
DK - Danimarca 2
GA - Gabon 2
GD - Grenada 2
GT - Guatemala 2
LB - Libano 2
PR - Porto Rico 2
PT - Portogallo 2
SS - ???statistics.table.value.countryCode.SS??? 2
SV - El Salvador 2
TH - Thailandia 2
AF - Afghanistan, Repubblica islamica di 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CG - Congo 1
CI - Costa d'Avorio 1
FK - Isole Falkland (Malvinas) 1
GY - Guiana 1
HU - Ungheria 1
Totale 34.129
Città #
Fairfield 2.681
Woodbridge 2.480
Ashburn 1.837
Singapore 1.730
Houston 1.576
Jacksonville 1.139
Seattle 1.060
Chandler 993
Ann Arbor 892
Wilmington 879
Hong Kong 874
Cambridge 857
Santa Clara 674
Beijing 668
Izmir 412
Warsaw 390
Nanjing 335
Los Angeles 265
Princeton 251
San Diego 233
Dallas 204
Boardman 194
Ferrara 150
Ho Chi Minh City 146
Munich 142
New York 140
Milan 126
Addison 121
Dong Ket 96
Shanghai 95
Nanchang 94
São Paulo 92
Shenyang 91
Mexico City 88
Hefei 82
Jakarta 82
Hanoi 78
Dearborn 76
Hebei 68
Tianjin 68
Chicago 60
London 59
Mountain View 59
Jinan 57
Bremen 55
Jiaxing 53
Brooklyn 47
The Dalles 45
Changsha 44
Kunming 42
Turku 42
Falls Church 40
Moscow 40
Montreal 39
Redwood City 39
San Francisco 38
Hangzhou 36
Rio de Janeiro 36
San Mateo 36
Columbus 35
Norwalk 35
Tokyo 35
Falkenstein 34
Guangzhou 33
Atlanta 32
Zhengzhou 32
Brussels 31
Buffalo 31
Denver 30
Johannesburg 29
Boston 28
Poplar 28
Tappahannock 28
Toronto 28
Orange 27
Rome 27
Stockholm 27
Manchester 26
Ningbo 26
Nuremberg 26
Orem 26
Belo Horizonte 25
Des Moines 25
Phoenix 24
Verona 24
Auburn Hills 23
Taizhou 23
Chennai 22
Washington 22
Brasília 21
Philadelphia 20
Tashkent 20
Amsterdam 19
Helsinki 18
Porto Alegre 18
Vienna 18
Biên Hòa 17
Curitiba 16
Mumbai 16
Bologna 15
Totale 24.366
Nome #
Anti-miR-135b in colon cancer treatment: Results from a preclinical study. 308
Anti-leukemic activity of microRNA-26a in a chronic lymphocytic leukemia mouse model 259
Circulating miR-106b-3p, miR-101-3p and miR-1246 as diagnostic biomarkers of hepatocellular carcinoma 247
Loss of miR-204 expression is a key event in melanoma 243
Liver tumorigenicity promoted by microRNA-221 in a mouse transgenic model 233
Breast cancer signatures for invasiveness and prognosis defined by deep sequencing of microRNA. 232
13q14 deletions in chronic lymphoproliferative disorders with the t(11;14)(q13;q32): a cytogenetic and interphase cytogenetic study. 232
13q14 deletion in non-Hodgkin's lymphoma: Correlation with clinicopathologic features 232
A novel t(9;11)(p22;q23) with ALL-1 gene rearrangement associated with progression of a myeloproliferative disorder to acute myeloid leukemia 229
Screen for MicroRNA and Drug Interactions in Breast Cancer Cell Lines Points to miR-126 as a Modulator of CDK4/6 and PIK3CA Inhibitors 221
MicroRNA profiling for the identification of cancers with unknown primary tissue-of-origin 215
miRNA signatures associate with pathogenesis and progression of osteosarcoma. 214
A microRNA signature defines chemoresistance in ovarian cancer through modulation of angiogenesis 211
A set of NF-κB-regulated microRNAs induces acquired TRAIL resistance in Lung cancer 208
Identification of microRNA activity by Targets' Reverse EXpression. 207
miR-27a and miR-27a* contribute to metastatic properties of osteosarcoma cells 206
Anti-miR-135b in colon cancer treatment: Results from a preclinical study. 204
MicroRNA e cancro 204
Chromosome aberrations in atypical chronic lymphocytic leukemia: a cytogenetic and interphase cytogenetic study 203
The downregulation of miR-125b in chronic lymphocytic leukemias leads to metabolic adaptation of cells to a transformed state. 203
Alterations of the tumor suppressor gene ARLTS1 in ovarian cancer 202
A microRNA DNA methylation signature for human cancer metastasis 199
Ectopic expression of PLC-β2 in non-invasive breast tumor cells plays a protective role against malignant progression and is correlated with the deregulation of miR-146a 195
Estrogen Mediated-Activation of miR-191/425 Cluster Modulates Tumorigenicity of Breast Cancer Cells Depending on Estrogen Receptor Status 192
miR-181b is a biomarker of disease progression in chronic lymphocytic leukemia 191
MicroRNA Expression Profiling in the Histological Subtypes of Barrett's Metaplasia 191
Reprogramming of miRNA networks in cancer and leukemia 190
An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues 190
p53 regulates epithelial-mesenchymal transition through microRNAs targeting ZEB1 and ZEB2. 189
Insulin growth factor signaling is regulated by microRNA-486, an underexpressed microRNA in lung cancer 189
A microRNA signature for a BMP2-induced osteoblast lineage commitment program 189
Transcriptional map of 170-kb region at chromosome 11p15.5: Identification and mutational analysis of the BWR1A gene reveals the presence of mutations in tumor samples 188
In vivo NCL targeting affects breast cancer aggressiveness through miRNA regulation 188
Investigations on microRNAs in human chronic lymphocytic leukemia and control of cancer-associated molecular pathways 187
MicroRNA involvement in hepatocellular carcinoma 186
A mouse model of the fragile gene FHIT: From carcinogenesis to gene therapy and cancer prevention 185
Adenoviral transduction of TESTIN gene into breast and uterine cancer cell lines promotes apoptosis and tumor reduction in vivo 183
MicroRNA expression profiling in human Barrett's carcinogenesis. 182
PP2A-activating drugs selectively eradicate TKI-resistant chronic myeloid leukemic stem cells 182
miR-21 and miR-155 are associated with mitotic activity and lesion depth of borderline melanocytic lesions. 181
The different epidemiologic subtypes of Burkitt lymphoma share a homogenous micro RNA profile distinct from diffuse large B-cell lymphoma 181
MicroRNA-31 predicts the presence of lymph node metastases and survival in patients with lung adenocarcinoma 180
MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1 180
Stem cell-like micro-RNA signature driven by Myc in aggressive liver cancer 180
A microRNA signature of hypoxia 180
MiR-199a-3p regulates mTOR and c-Met to influence the doxorubicin sensitivity of human hepatocarcinoma cells 178
Onconase mediated NFKβ downregulation in malignant pleural mesothelioma 175
microRNA-135b promotes cancer progression acting as a downstream effector of oncogenic pathways in colon cancer 173
Resveratrol decreases the levels of miR-155 by upregulating miR-663, a microRNA targeting JunB and JunD 172
B-cell malignancies in microRNA Eμ-miR-17~92 transgenic mice 171
Association of a microRNA/TP53 feedback circuitry with pathogenesis and outcome of B-cell chronic lymphocytic leukemia 171
Transcription signatures encoded by ultraconserved genomic regions in human prostate cancer. 168
In hepatocellular carcinoma miR-519d is up-regulated by p53 and DNA hypomethylation and targets CDKN1A/p21, PTEN, AKT3 and TIMP2 167
Strong inverse correlation between MicroRNA-125b and human papillomavirus DNA in productive infection 167
Intramitochondrial calcium regulation by the FHIT gene product sensitizes to apoptosis 167
Extensive modulation of a set of microRNAs in primary glioblastoma 165
MicroRNA-148a reduces tumorigenesis and increases TRAIL-induced apoptosis in NSCLC 165
Espressione dei MicroRNA nei carcinomi mammari 165
mRNA/microRNA gene expression profile in microsatellite unstable colorectal cancer 164
Aberrant FHIT transcripts in Merkel cell carcinoma 164
Implications of the miR-10 family in chemotherapy response of NPM1-mutated AML 164
ALL1 fusion proteins induce deregulation of EphA7 and ERK phosphorylation in human acute leukemias 163
Knockout mice reveal a tumor suppressor function for Testin 163
MiR-145 participates with TP53 in a death promoting regulatory loop and targets estrogen receptor in human breast cancer cells 162
MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B 159
Gain of imprinting at chromosome 11p15: a pathogenetic mechanism identified in human hepatocarcinomas 159
Significance of Aberrant Expression of MicroRNAs in Cancer Cells 158
microRNA-29 can regulate expression of the long non-coding RNA gene MEG3 in hepatocellular cancer 158
miR-181b as a therapeutic agent for chronic lymphocytic leukemia in the Eµ-TCL1 mouse model 157
Identification of differentially expressed microRNAs by microarray: A possible role for microRNA genes in pituitary adenomas 157
Specific microRNAs are downregulated in human thyroid anaplastic carcinomas 156
Loss of miR-125b-1 contributes to head and neck cancer development by dysregulating TACSTD2 and MAPK pathway 156
Tumor suppressor functions of ARLTS1 in lung cancers 156
Cytogenetic and interphase cytogenetic characterization of atypical chronic lymphocytic leukemia carrying BCL1 translocation 156
Cytogenetic profile of lymphoma of follicle mantle lineage: Correlation with clinicobiologic features 155
MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis 155
WW domain-containing proteins, WWOX and YAP, compete for interaction with ErbB-4 and modulate its transcriptional function 154
MicroRNA genes are frequently located near mouse cancer susceptibility loci 153
The role of microRNA genes in papillary thyroid carcinoma 153
Levels of miR-126 and miR-218 are elevated in ductal carcinoma in situ (DCIS) and inhibit malignant potential of DCIS derived cells 153
Mutator activity induced by microRNA-155 (miR-155) links inflammation and cancer 152
The role of p19 and p21 H-Ras proteins and mutants in miRNA expression in cancer and a Costello syndrome cell model 151
MicroRNA deregulation in human thyroid papillary carcinomas 151
Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF- α stimulation and their possible roles in regulating the response to endotoxin shock 150
Low frequency of alterations of the alpha (PPP2R1A) and beta (PPP2R1B) isoforms of the subunit A of the serine-threonine phosphatase 2A in human neoplasms 149
Genomic profiling of microRNA and messenger RNA reveals deregulated microRNA expression in prostate cancer 149
Characterization of t(11;14) translocation in mantle cell lymphoma by fluorescent in situ hybridization 148
Oncogenic role of miR-483-3p at the IGF2/483 locus 148
MicroRNA profiles discriminate among colon cancer metastasis 148
MicroRNA-133 controls cardiac hypertrophy 147
MicroRNA-135b promotes cancer progression acting as a downstream effector of oncogenic pathways in colon cancer 147
TCL1 transgenic mouse model as a tool for the study of therapeutic targets and microenvironment in human B-cell chronic lymphocytic leukemia 146
MicroRNA-221 targets Bmf in hepatocellular carcinoma and correlates with tumor multifocality 146
MicroRNA microarray identifies Let-7i as a novel biomarker and therapeutic target in human epithelial ovarian cancer 145
microRNA involvement in hepatocellular carcinoma 144
WWOX and p53 dysregulation synergize to drive the development of osteosarcoma 144
Suppression of MicroRNA-9 by Mutant EGFR signaling upregulates FOXP1 to enhance glioblastoma tumorigenicity 144
MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells 144
TCL1 promotes blastomere proliferation through nuclear transfer, but not direct phosphorylation, of AKT/PKB in early mouse embryos 143
Functional Implications of MicroRNAs in Acute Myeloid Leukemia by Integrating MicroRNA and Messenger RNA Expression Profiling 143
Totale 17.809
Categoria #
all - tutte 157.447
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.311
Totale 158.758


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.067 0 0 0 0 0 340 155 389 98 406 401 278
2021/20222.731 124 318 263 67 95 108 151 135 80 201 287 902
2022/20232.423 249 98 61 306 380 391 103 259 323 19 131 103
2023/20241.074 126 169 60 38 79 182 32 69 23 18 30 248
2024/20254.586 144 94 387 137 585 360 160 283 851 471 649 465
2025/20267.065 1.194 650 1.219 1.860 1.889 253 0 0 0 0 0 0
Totale 34.468